[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: Hydroxichloroqune (produced by any pharmacutical company in Iran), administered orally, 400mg (bid) on the first day followed by 200mg/bid/day for the next 4 days (days 1-5) with or without Naproxen and with or without Azythromycin", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group:Favipiravir administered orally, produced by the Dr. Abidi pharmacutical Co, Iran, 3200mg (1600/ bid) on the first day followed by 1200mg (600mg/bid) daily for the next 4 days (days 1-5)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]